![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > Northern Europe
Please find below persons from Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden and the UK as well as related to organisations from these countries.Total search results: 4148 | Ordered by Country (ascending)
1 2 3 ... 40 41 42 
  Person |
Position |
Organisation (Group) |
 Country |
|---|---|---|---|
| Waterhouse, Oliver J. (Base Genomics 201907– CEO + Founder) | Chief Executive Officer (CEO) | Exact Sciences (Group) | United Kingdom (GB) |
| Waterman, Sally (OBN 2014–201812 Board Chairman) | Board member, non-executive | OBN (UK) Ltd. | United Kingdom (GB) |
| Waterworth, Toby Wilson (Atlantic Healthcare plc 201603 CEO) | Chief Executive Officer (CEO) | Atlantic Healthcare plc | United Kingdom (GB) |
| Watkin, David J. (Univ Oxford 201009 Dept Chemistry Director Chemical Crystallography Lab) | Researcher (university / research institute) | University of Oxford | United Kingdom (GB) |
| Watson, Dave (Univ Strathclyde 201003 Prof + ScotMet) | Professor | University of Strathclyde (Glasgow) | United Kingdom (GB) |
| Watson, David (Lhasa Ltd 201302 CEO) | Chief Executive Officer (CEO) | Lhasa Ltd. | United Kingdom (GB) |
| Watson, Lorna (Northbank Communications 200608 Senior Account Manager) | n. a. | Instinctif Partners (Group) | United Kingdom (GB) |
| Watson, Michael (VaxEquity 202109 Executive Chairman) | Board member, executive | VaxEquity Ltd. (VXT) | United Kingdom (GB) |
| Watson, Nicola (Schauenburg 201412 at Markes international) | n. a. | Schauenburg (Group) | United Kingdom (GB) |
| Watson, Tim (Instinctif Partners 201807) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | United Kingdom (GB) |
| Watt, Alan (NodThera Ltd 201806 CSO + acting CEO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | NodThera Ltd. | United Kingdom (GB) |
| Watt, Fiona (Univ Cambridge 201203 Professor of Molecular Genetics) | Professor | University of Cambridge | United Kingdom (GB) |
| Watts, Sam (Stratophase 201110 Business Development + Commercial Officer + co-founder) | Business Development Manager / Strategy Manager | Stratophase Ltd. | United Kingdom (GB) |
| Watts, Tim (Oxford BioMedica 2012–201709 CFO RETIRED 9/17) | Chief Financial Officer (CFO) | Oxford Biomedica (Group) | United Kingdom (GB) |
| Weatherall, Jim (AstraZeneca 202110 VP Data Science + Ai, RnD) | President/Director/Head Business Group/Unit/Division | AstraZeneca (Group) | United Kingdom (GB) |
| Weaver, Richard (XenoGesis 201109– Managing Director + Founder before AstraZeneca R&D) | Managing Director | Sygnature Discovery (Group) | United Kingdom (GB) |
| Weaver, Tom (Congenica 201309– CEO before MRC + Source BioScience formerly Medical Solutions + Geneservice) | Chief Executive Officer (CEO) | Congenica (Group) | United Kingdom (GB) |
| Webb, Andrew (EKF Diagnostics 201303– CEO of EKF Molecular Diagnostics before Qiagen/DxS + Amersham Pharmacia Biotech) | Chief Executive Officer (CEO) | EKF Diagnostics (Group) | United Kingdom (GB) |
| Webb, Mike (Delta Diagnostics (UK) 201310– Operations Director + Co-owner before Hologic + Gen-Probe + Tepnel) | General Manager (management) | Yourgene Health (Group) | United Kingdom (GB) |
| Webber, Guy (Quotient Bioresearch 201003 Head of In Vitro Sciences) | n. a. | Quotient Bioresearch (Group) | United Kingdom (GB) |
| Wedlake, Bill (NextPharma 200301– CEO before CFO since 7/00) | Chief Executive Officer (CEO) | NextPharma (Group) | United Kingdom (GB) |
| Weedon, Dimitrios (OrbiMed 202305– Managing Director in new London Office) | Managing Director | OrbiMed (Group) | United Kingdom (GB) |
| Wei, Liangshen (Horizon Discovery 201611 Head of Emerging Markets Team) | Business Development Manager / Strategy Manager | PerkinElmer (Group) | United Kingdom (GB) |
| Weinberger, Paul (Lumora 201005– Chief Marketing Officer before Roche Diagnostics + Enigma Diagnostics) | Sales Manager / Marketing Manager | Erba Diagnostics Mannheim (Group) | United Kingdom (GB) |
| Weinstein, Edward (Horizon Discovery 201607 President of Services Business) | President/Director/Head Business Group/Unit/Division | PerkinElmer (Group) | United Kingdom (GB) |
| Weir, Malcolm (Heptares 2007– CEO + co-founder before Inpharmatica 2000–2006 CEO before GSK/Glaxo since 1983) | Chief Executive Officer (CEO) | Sosei (Group) | United Kingdom (GB) |
| Weir, Neil (Sitryx Therapeutics 201804– CEO before UCB SVP Discovery) | Chief Executive Officer (CEO) | Sitryx Therapeutics Ltd. | United Kingdom (GB) |
| Wells, Glenn (Wellcome Trust 200809 BusDev Manager) | Business Development Manager / Strategy Manager | Wellcome Trust, The | United Kingdom (GB) |
| Welsh, Chris (Consilium Strategic Communications 201707) | Public Relations Manager / Investor Relations Manager | ICR (Group) | United Kingdom (GB) |
| Werner, Thomas (Board Member of several companies before GSK SVP) | Board member, non-executive | GSK (Group) | United Kingdom (GB) |
| West, Stuart (Biocatalysts Ltd 201803 Managing Director) | Managing Director | BRAIN Biotech (Group) | United Kingdom (GB) |
| West, Will (CellCentric –200710– CEO + Morningside Ventures 202109) | Chief Executive Officer (CEO) | CellCentric Ltd. | United Kingdom (GB) |
| Westby, Mike (Agalimmune 201406 CEO) | Chief Executive Officer (CEO) | BioLineRx (Group) | United Kingdom (GB) |
| Westrop, Rod (Axordia 200610 Commercial Director) | n. a. | Axordia Ltd. | United Kingdom (GB) |
| Wetekam, Volker (General Electric 201205– CEO + President of GE Healthcare Germany before AGFA HealthCare + Siemens) | Chief Executive Officer (CEO) | General Electric (Group) | United Kingdom (GB) |
| Wetzel, Bernd (SR Pharma 200507 non-executive Director) | Board member, non-executive | Silence Therapeutics (Group) | United Kingdom (GB) |
| Wheeler, Jeremy (BioCaptiva 202204– CEO) | Chief Executive Officer (CEO) | BioCaptiva Ltd. | United Kingdom (GB) |
| Whetton, Tony (Univ Manchester 201510 Prof + Director of Stoller Biomarker Discovery Center) | Professor | University of Manchester (UoM) | United Kingdom (GB) |
| Whileman, David (Inflexion 202301 Head of Partnership Capital) | Investment Manager | Inflexion (Group) | United Kingdom (GB) |
| Whitaker, Paul (Biosilta 201604 Managing Director) | Managing Director | BioSilta (Group) | United Kingdom (GB) |
| Whitcombe, David (Dxs 200812 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Qiagen (Group) | United Kingdom (GB) |
| White, Amanda (Health Data Research UK 201807 Director of Communications + Marketing) | Public Relations Manager / Investor Relations Manager | Health Data Research UK | United Kingdom (GB) |
| White, Colin (Perceptive Instruments 201311 Managing Director) | Managing Director | Instem (Group) | United Kingdom (GB) |
| White, James (Osmetech 200511 CEO) | Chief Executive Officer (CEO) | Roche (Group) | United Kingdom (GB) |
| Whitehead, Carlene (Danaher 201204 European MarCom Specialist at Molecular Devices UK) | Public Relations Manager / Investor Relations Manager | Danaher (Group) | United Kingdom (GB) |
| Whitehead, Stephen (ABPI 201211 Chief Executive) | Chief Executive Officer (CEO) | ABPI (Association of the British Pharmaceutical Industry) | United Kingdom (GB) |
| Whitehurst, Peter (Arcis:Altos 201810 CEO of Arcis Biotechnology) | Chief Executive Officer (CEO) | Arcis:Altos (Group) | United Kingdom (GB) |
| Whiteley, Nick (European Spectrometry Systems founder) | Company Founder | European Spectrometry Systems Ltd. (ESS) | United Kingdom (GB) |
| Whitmore, Terry (Henniker Scientific 200901– founder) | Company Founder | Henniker Scientific Ltd. | United Kingdom (GB) |
| Whittingham, Jerel (Myconostica 200804 CEO) | Chief Executive Officer (CEO) | Novacyt (Group) | United Kingdom (GB) |
| Whittley, Nadia (Arquer Diagnostics 201612– CEO before Tefen Management Consulting + Alium Medical + Allergan) | Chief Executive Officer (CEO) | Arquer Diagnostics Ltd. | United Kingdom (GB) |
| Whyatt, Fiona (Ramarketing 202211) | Public Relations Manager / Investor Relations Manager | Ramarketing (Group) | United Kingdom (GB) |
| Wicks, Jim (PrimerDesign Ltd 201201 Managing Director) | Managing Director | Novacyt (Group) | United Kingdom (GB) |
| Widdowson, Caroline (Schauenburg 201412 promoted Produt Marketing Manager Thermal Desorption at Markes) | Sales Manager / Marketing Manager | Schauenburg (Group) | United Kingdom (GB) |
| Widdowson, Peter S. (Quethera 201808 CEO) | Chief Executive Officer (CEO) | Astellas (Group) | United Kingdom (GB) |
| Wiederhold, Bob (Synthace 202105 Board Chairman) | Board member, non-executive | Synthace (Group) | United Kingdom (GB) |
| Wiener, Albrecht (Eppendorf UK 200704 Managing Director) | Managing Director | Eppendorf (Group) | United Kingdom (GB) |
| Wilcockson, Mark (United Kingdom (govt) 202210 at British Business Bank) | Investment Manager | Mercia (Group) | United Kingdom (GB) |
| Wilde, Lars Christian (Compass Pathways 202004 CBO + Co-Founder) | Chief Business Officer (CBO) | Compass Pathways (Group) | United Kingdom (GB) |
| Wilkie, James (Univ Birmingham 201410 CEO of Alta Innovations) | Chief Executive Officer (CEO) | University of Birmingham | United Kingdom (GB) |
| Wilkinson, Malcolm (Kirkstall 201802 CEO) | Chief Executive Officer (CEO) | Kirkstall (GB) | United Kingdom (GB) |
| Willcocks, Spike (Oxford NanoLabs 200702 Director of Business Development) | Business Development Manager / Strategy Manager | Oxford Nanopore (Group) | United Kingdom (GB) |
| Willetts, David (United Kingdom (govt) 201205 Minister for Universities and Science) | Minister | United Kingdom (GB) (govt) | United Kingdom (GB) |
| Williams, Andrew (Halma 201011 CEO) | Chief Executive Officer (CEO) | Halma (Group) | United Kingdom (GB) |
| Williams, Andrew (LabLogic Systems 200801– before Leeds University) | Sales Manager / Marketing Manager | LabLogic (Group) | United Kingdom (GB) |
| Williams, Antony (RSC 200905– VP Strategic Development before ChemZoo 200804 President) | n. a. | Royal Society of Chemistry, The (RSC) | United Kingdom (GB) |
| Williams, David (Nanna Therapeutics 202004 CEO before Discuva) | Chief Executive Officer (CEO) | Astellas (Group) | United Kingdom (GB) |
| Williams, Doris-Ann (BIVDA 200705 Director General) | General Manager (management) | BIVDA (British In Vitro Diagnostic Regulatory Association) | United Kingdom (GB) |
| Williams, Jon (Aquapharm Biodiscovery 201207 VP Commercial) | Chief Commercial Officer (CCO) | Aquapharm Biodiscovery Ltd. | United Kingdom (GB) |
| Williams, Nick (Medicxi 202206) | n. a. | Medicxi Ventures (formerly Index Ventures Life Sciences) | United Kingdom (GB) |
| Williams, Richard (AstraZeneca 200707 CIO) | n. a. | AstraZeneca (Group) | United Kingdom (GB) |
| Williams, Sam (IP Group 201411 CEO of Modern Biosciences plc) | Chief Executive Officer (CEO) | IP Group (Group) | United Kingdom (GB) |
| Williamson, Alison (BioCaptiva 202204– CFO before Dysis Medical + Aircraft Medical + Deloitte + RMD + KPMG) | Chief Financial Officer (CFO) | BioCaptiva Ltd. | United Kingdom (GB) |
| Williamson, Andrew (Cambridge Innovation Capital 201906 Managing Partner) | Managing Partner (investment firm) | Cambridge Innovation Capital (Group) | United Kingdom (GB) |
| Williamson, David (Nova Capital Management 200710 Managing Director) | Managing Director | Nova Capital (Group) | United Kingdom (GB) |
| Williamson, Jerry (Genetix 200801– President US Operations) | n. a. | Danaher (Group) | United Kingdom (GB) |
| Willingham, Finn (Angel Biotechnology 200602) | n. a. | Angel Biotechnology (Group) | United Kingdom (GB) |
| Wilson, Dominic (Bryan Garnier 201709– Managing Director at European Healthcare division before Zeus Capital + Nomura) | Managing Director | Bryan, Garnier & Co., Ltd. | United Kingdom (GB) |
| Wilson, Edmund (Titian Software 201206 CEO) | Chief Executive Officer (CEO) | Titian Software (Group) | United Kingdom (GB) |
| Wilson, Genevieve (Consilium Strategic Communications 202109) | Public Relations Manager / Investor Relations Manager | ICR (Group) | United Kingdom (GB) |
| Wilson, Ian (Imperial College London 201208– Professor before AstraZeneca Senior Principle Scientist) | Professor | Imperial College London | United Kingdom (GB) |
| Wilson, Julia (Achilles Therapeutics 202011 Head of Communications + JW Communications 201209– before Vectura Group) | Public Relations Manager / Investor Relations Manager | JW Communications Ltd. | United Kingdom (GB) |
| Wilson, Keith (Oxford BioTherapeutics 201506 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Oxford BioTherapeutics Ltd. (OBT) | United Kingdom (GB) |
| Wilson, Rod (Peak Scientific 201606 Senior South East Asia Territory Manager) | Regional manager | Peak Scientific (Group) | United Kingdom (GB) |
| Wilson, Sarah (Consilium Strategic Communications 201903) | Public Relations Manager / Investor Relations Manager | ICR (Group) | United Kingdom (GB) |
| Wilson, Tim (Igem Therapeutics 201804 CEO) | Chief Executive Officer (CEO) | Igem Therapeutics Ltd. | United Kingdom (GB) |
| Wilson, Tom (Seedcamp 202402 Partner) | Partner (venture partner) | Seedcamp (GB) | United Kingdom (GB) |
| Wilson, Vicki (DxS 200808– Diagnostics Product Manager before Invitrogen + Bayer Diagnostics + Tecan + Dade Behring) | Product Manager (personnel) | Qiagen (Group) | United Kingdom (GB) |
| Winder, Rob (FTI Consulting 201412) | Public Relations Manager / Investor Relations Manager | FTI Consulting (Group) | United Kingdom (GB) |
| Winter, Gregory (MRC + CAT + Domantis + Nobel Laureate) | Professor | United Kingdom (GB) (govt) | United Kingdom (GB) |
| Winterhalter, Karen (Onyx Health PR 201808 Managing Director + Founder) | Public Relations Manager / Investor Relations Manager | Onyx Health Ltd. (Onyx Health PR) | United Kingdom (GB) |
| Wise, Alan (IOmet Pharma 201601 CEO) | Chief Executive Officer (CEO) | Merck (US) (MSD) (Group) | United Kingdom (GB) |
| Wise, James (Balderton Capital 202204 Partner) | Partner (venture partner) | Balderton Capital (UK) LLP | United Kingdom (GB) |
| Withey, Fiona (TrakCel 202002– CEO + Co-Founder before PCI Pharma Services + Biotec Services International) | Chief Executive Officer (CEO) | TrakCel (Group) | United Kingdom (GB) |
| Wittendorff, Jørgen (Silence Therapeutics 201908– Head of Manufacturing before Ablyn + Ferring + Novo Nordisk) | Production Manager | Silence Therapeutics (Group) | United Kingdom (GB) |
| Wlodek, Aleksandra M. (Ola) (Constructive Biology 202207– CEO before Reflection Therapeutics) | Chief Executive Officer (CEO) | Constructive Biology Ltd. (Constructive Bio) | United Kingdom (GB) |
| Wolf, Stefan (Binding Site 202210 CEO before Thermo Fisher + Siemens + Dade Behring) | Chief Executive Officer (CEO) | Thermo Fisher (Group) | United Kingdom (GB) |
| Wolf-Ahrens, Patricia (LifeScience Connect 202309) | n. a. | LifeScience Connect Ltd. (LifeScience ORG) | United Kingdom (GB) |
| Wolfson, Andrew (Pembroke 202302 CEO of Pembroke Investment Managers) | Chief Executive Officer (CEO) | Pembroke (Group) | United Kingdom (GB) |
| Wollman, Lilly (Generation Investment Management 201901 Co-Head Growth Equity Team) | Investment Manager | Generation Investment Management LLP | United Kingdom (GB) |
1 2 3 ... 40 41 42
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
